Journal of Pineal Research · 1993 · 69 citations · 21 references
MedicineOncologyPharmacologyCancer PharmacologyCellular PharmacologyMolecular OncologyOncology PharmacologyPharmacodynamics Of Anticancer AgentsAdverse Effect CharacterizationAnticancer ActivityAntiproliferative Drug ActionCancer Cell Culture ModelsCancer Cell Proliferation InhibitionIndole AlkaloidsIndole ChemistryIndole Derivatives
The in vitro antiproliferative action of pineal indoles on several tumor cell lines including melanoma (B16), sarcoma (S180), macrophage-like cell line (PU5), fibroblasts (3T3), and choriocarcinoma (JAr) was examined by measuring the incorporation of 3H-thymidine by the tumor cells, and, in the case of melanoma cells, by also measuring the incorporation of 3H-leucine and 3H-uridine. Uptake of crystal violet was used to assess the viability of the tumor cells. The order of inhibitory potency of the indoles was found to be methoxytryptamine > melatonin, methoxytryptophol, hydroxytryptophol, and methoxyindoleacetic acid > serotonin and hydroxyindoleacetic acid. The possibility of an adverse effect of the indoles on the viability of normal cells was also investigated by employing a primary culture of rat hepatocytes. The release of glutamate-oxaloacetate transaminase by hepatocytes was not affected by the indoles, although the release of glutamate-pyruvate transaminase was increased to a small extent and the uptake of crystal violet was slightly inhibited.
21
Bill L. Kreamer, Jeffrey L. Staecker, Norimasa Sawada et al. · In Vitro Cellular & Developmental Biology - Plant · 1986 · 385 citations
Melatonin: Clinical perspectives
Comparative Biochemistry and Physiology Part A Physiology · 1989 · 140 citations